Drug Profile
Rotavirus vaccine I321 - Bharat Biotech
Alternative Names: I321 - Bharat Biotech; I321 AGMK; Live attenuated Indian rotavirus vaccine candidate strain I321 - Bharat BiotechLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Indian Institute of Science; Stanford University
- Developer Bharat Biotech
- Class Rotavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Rotavirus infections
Most Recent Events
- 16 Apr 2021 No development reported - Phase-III for Rotavirus infections (Prevention) in India (PO) (Bharat Biotech pipeline, April 2021)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Rotavirus-infections(Prevention) in USA (PO)
- 28 Jun 2005 Phase-II clinical trials in Rotavirus infections in India (PO)